,;where e is base of natural logarithm, e = 2.72, Z is calculated by formula Z = (-5.1 + (0.08) * x + (0.066) * y), x is content of IL-17 in blood serum in pg/ml, y – content of IL-6 in blood serum in pg/ml, and risk of developing adverse cardiovascular events is considered to be high while value K ≥ 0.13, and low – while K 0.13.;EFFECT: use of the method enables higher accuracy of assessing the risk of unfavorable outcomes for 1 year after the percutaneous coronary intervention with stenting in the patients with stable coronary artery disease, which in turn will allow optimizing the therapeutic approach in these patients.;1 cl, 1 dwg, 3 tbl, 2 ex"/>
公开/公告号RU2692257C1
专利类型
公开/公告日2019-06-24
原文格式PDF
申请/专利权人 OREKHOVA YULIYA NIKOLAEVNA;
申请/专利号RU20180129821
发明设计人 OREKHOVA YULIYA NIKOLAEVNA (RU);IVANCHENKO DARYA NIKOLAEVNA (RU);DEMIDOVA ALEKSANDRA ALEKSANDROVNA (RU);SHLYK SERGEJ VLADIMIROVICH (RU);SIZYAKINA LYUDMILA PETROVNA (RU);DOROFEEVA NATALYA PETROVNA (RU);TER-AKOPYAN ALEKSANDRA OVANESOVNA (RU);CHEBOTOVA ANASTASIYA IVANOVNA (RU);
申请日2018-08-15
分类号G01N33/49;A61B10;
国家 RU
入库时间 2022-08-21 11:46:09